Clinical trial PanCO
An open label, single arm pilot study of OncoSilTM, administered to study participants with unresectable locally advanced pancreatic adenocarcinoma, given in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies
Cancers | |
---|---|
Organ | pancreas |
Trial status | Trial closed |
Investigator | |
Trial type |
Medical devices
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | OncoSil Medical |
BECT Identifier | B079201732538 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03003078 |
Inclusion criteria | Target tumour diameter of ? 2.0 cm (shortest axis) |
Last update |